Xavier de Castella Height, Weight, Net Worth, Age, Birthday, Wikipedia, Who, Instagram, Biography

Xavier de Castella was the well known accomplice of one of the greatest Japenese-French Fashion Designer Kenzo Takada.

Xavier was quite a committed and decided lady who upheld Kenzo during his development in the style business.

She remained with him and upheld all his developments to arrive at a specific tallness in the field of style.

Xavier de Castella’s accomplice Kenzo as of late on October 4, 2020, died from COVID-19 in Paris as he was admitted to the American Hospital of Paris.

Kenzo had lost his accomplice Xavier route back in 1990 from AIDS and simply a year later lost his mom which influenced him a ton intellectually just as physically.

Name Xavier de Castella
Gender Female
Nationality Japanese
Married/Single In a relationship

Xavier de Castella was born in Japan presumably during the 1940s. Xavier’s age at the hour of her demise presumably would have been in the later 40’s anyway he age isn’t revealed at this point.

Xavier de Castella was a Japanese lady who was involved with Kenzo Takada who assisted him with procuring his greater fortune and his energy for planning.

Xavier and her accomplice Kenzo Takada didn’t have any kid together anyway they were near one another and were extremely steady.

In spite of being a prestigious individual and an accomplice of world-renowned style originator Kenzo, Xavier isn’t highlighted in the Wikipedia yey.

Xavier isn’t accessible on her Instagram while her accomplice Kenzo is accessible @kenzotakada_official where he has more than 16k adherents.

Xavier’s accomplice Kenzo is a proprietor of scent, skin health management items, and garments which is under a brand named Kenzo as it was established route back in 1970.

She hasn’t referenced her total assets anyway he accomplice Kenzo’s total assets starting at 2020 is in excess of 100 million dollars.

Xavier died in 1990 because of AIDS. Late Xavier de Castella’s accomplice Kenzo passed on October 4, 2020, because of COVID-19.